Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Sep 1;160(9):1001-1003.
doi: 10.1001/jamadermatol.2024.2378.

Upadacitinib for Treatment of Granulomatous Cheilitis

Axel De Greef  1   2 , Caroline Peeters  1 , Olivier Dewit  3   4 , Laurence de Montjoye  1   2 , Marie Baeck  1   2
Affiliations
Case Reports

Upadacitinib for Treatment of Granulomatous Cheilitis

Axel De Greef et al. JAMA Dermatol. .
No abstract available

Plain language summary

This case series examines the effectiveness of the Janus kinase inhibitor upadacitinib for the treatment of granulomatous cheilitis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Drs De Greef, Dewit, and Baeck reported receiving personal fees from AbbVie outside the submitted work. Dr de Montjoye reported receiving nonfinancial support from Lilly and Sanofi and personal fees from Novartis outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Clinical Evolution of Patient 1 With Upadacitinib
Clinical aspect of granulomatous cheilitis before (A) and after (B) 4 months of treatment with upadacitinib, 30 mg.
See this image and copyright information in PMC

References

    1. Wiesenfeld D, Ferguson MM, Mitchell DN, et al. . Oro-facial granulomatosis—a clinical and pathological analysis. Q J Med. 1985;54(213):101-113. - PubMed
    1. Miest R, Bruce A, Rogers RS III. Orofacial granulomatosis. Clin Dermatol. 2016;34(4):505-513. doi:10.1016/j.clindermatol.2016.02.024 - DOI - PubMed
    1. Eubanks BN, Seykora CM, Bandino JP. Granulomatous cheilitis preceding gastrointestinal manifestations of Crohn’s disease. Am J Dermatopathol. 2023;45(7):482-486. doi:10.1097/DAD.0000000000002458 - DOI - PubMed
    1. Kreuter A, Koushk-Jalali B, Oellig F, Tigges C. Low response of granulomatous cheilitis to currently established treatments. J Eur Acad Dermatol Venereol. 2021;35(7):e453-e454. doi:10.1111/jdv.17208 - DOI - PubMed
    1. Chapman S, Gold LS, Lim HW. Janus kinase inhibitors in dermatology, part II: a comprehensive review. J Am Acad Dermatol. 2022;86(2):414-422. doi:10.1016/j.jaad.2021.06.873 - DOI - PubMed

Publication types

MeSH terms